Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Agid

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Early Intervention in Psychiatry|May 31, 2012
Specialized home treatment versus hospital-based outpatient treatment for first-episode psychosis: a randomized clinical trialCarolyn S Dewa, Robert B Zipursky, Nancy Chau, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|October 10, 2025
Placebo versus no treatment for people with schizophrenia: A systematic review and meta-analysisNobuyuki Nomura, Yutaro Shimomura, Yuhei Kikuchi, et al.
Journal of Clinical Psychopharmacology|December 27, 2011
Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trialGary Remington, Shitij Kapur, George Foussias, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2011
Time course of improvement with antipsychotic medication in treatment-resistant schizophreniaTakefumi Suzuki, Gary Remington, Tamara Arenovich, et al.
The American Journal of Psychiatry|April 4, 2007
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophreniaRomina Mizrahi, Pablo Rusjan, Ofer Agid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 2, 2006
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophreniaOfer Agid, David Mamo, Nathalie Ginovart, et al.
Schizophrenia Research|May 26, 2015
Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophreniaGagan Fervaha, Christina Hill, Ofer Agid, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 1, 2016
Values in First-Episode SchizophreniaOfer Agid, Krysta Mcdonald, Gagan Fervaha, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Impaired insight into illness is unrelated to subjective happiness, success, and life satisfaction in schizophreniaJulia Kim, Laura Romero, Yusuke Iwata, et al.
Schizophrenia Research|August 21, 2012
Happiness in first-episode schizophreniaOfer Agid, Krysta McDonald, Cynthia Siu, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Early Intervention in Psychiatry|May 31, 2012
Specialized home treatment versus hospital-based outpatient treatment for first-episode psychosis: a randomized clinical trialCarolyn S Dewa, Robert B Zipursky, Nancy Chau, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|October 10, 2025
Placebo versus no treatment for people with schizophrenia: A systematic review and meta-analysisNobuyuki Nomura, Yutaro Shimomura, Yuhei Kikuchi, et al.
Journal of Clinical Psychopharmacology|December 27, 2011
Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trialGary Remington, Shitij Kapur, George Foussias, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2011
Time course of improvement with antipsychotic medication in treatment-resistant schizophreniaTakefumi Suzuki, Gary Remington, Tamara Arenovich, et al.
The American Journal of Psychiatry|April 4, 2007
Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophreniaRomina Mizrahi, Pablo Rusjan, Ofer Agid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 2, 2006
Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophreniaOfer Agid, David Mamo, Nathalie Ginovart, et al.
Schizophrenia Research|May 26, 2015
Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophreniaGagan Fervaha, Christina Hill, Ofer Agid, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 1, 2016
Values in First-Episode SchizophreniaOfer Agid, Krysta Mcdonald, Gagan Fervaha, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Impaired insight into illness is unrelated to subjective happiness, success, and life satisfaction in schizophreniaJulia Kim, Laura Romero, Yusuke Iwata, et al.
Schizophrenia Research|August 21, 2012
Happiness in first-episode schizophreniaOfer Agid, Krysta McDonald, Cynthia Siu, et al.
Pageof 13